Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
Harvard Bioscience (Nasdaq: HBIO) will report financial results for the quarter ended March 31, 2026 before market open on May 12, 2026 and will host a conference call at 8:00 AM ET the same day to discuss results.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Harvard Bioscience (Nasdaq: HBIO) will report financial results for the quarter ended March 31, 2026 before market open on May 12, 2026 and will host a conference call at 8:00 AM ET the same day to discuss results.
Registration is required for analysts who wish to ask questions; an audio-only webcast will be available via the company investor website. Earnings release and slide presentation will be posted in Investor Relations.
Details
News Market Reaction – HBIO
On Apr 28, the day this news came out, HBIO closed 5.56% below the previous close.
Data tracked by StockTitan Argus for the Apr 28 session.
Key Figures
- Quarter end
- March 31, 2026
- Quarter for which results will be announced
- Earnings release date
- May 12, 2026
- Date Q1 2026 results to be released before market open
- Conference call time
- 8:00 a.m. ET
- Time of Q1 2026 earnings conference call
Previous Conferences,earnings Reports
-
Announced Q4 2025 results timing and 8:00 AM ET conference call.
-
Set Q3 2025 results date and conference call with webcast access.
-
Announced Q2 2025 earnings release and investor conference call.
-
Outlined Q1 2025 results release timing and call logistics.
-
Scheduled Q4 2024 earnings release and morning conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2026, before the market opens on May 12, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Analysts who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Company Contact:
Mark Frost
Chief Financial Officer
(508) 893-3120
investors@harvardbioscience.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.